Tag Archives: dementia

Viva EnVivo: EVP-6124 in Alzheimer’s

NIR has been waiting for the results of two particular clinical trials to be publicly released, since these programs have achieved the kind of success that should start to catalyze a shift in sentiment about prospects for CNS drug development. … Continue reading

Posted in Biotech, Science | Tagged , , , , | Leave a comment

Amyvid and Irrelevance

The FDA finally gave marketing approval to Lilly’s (via Avid) Amyvid/florbetapirradio-labeled imaging agent, for use in PET-scan identification of beta-amyloid plaque. Approval had been delayed due to concerns regarding interrater variability/reliability. But reliability is not, in our view, the biggest … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | 2 Comments